Stock listing
KYTX Stock Price, News, Filings & Events — Kyverna Therapeutics, Inc.
Selected listing: KYTX · BOATS · USD · US
This page tracks Kyverna Therapeutics, Inc.'s KYTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KYTX:BOATS. KYTX:BOATS is the stock-level entry point for investors researching Kyverna Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kyverna Therapeutics, Inc. (ticker: KYTX) is a public company based in the United States, focused on developing innovative therapies. With a market capitalization of approximately $450.5 million, Kyverna is positioned within the biotechnology sector. The company aims to advance its research and development efforts to address unmet medical needs.

- Ticker
- KYTX:BOATS
- Asset type
- Stock
- Market cap
- $449.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Kyverna Therapeutics, Inc. KYTX:BOATS stock context
This page tracks Kyverna Therapeutics, Inc.'s KYTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KYTX:BOATS. KYTX:BOATS is the stock-level entry point for investors researching Kyverna Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kyverna Therapeutics, Inc. (ticker: KYTX) is a public company based in the United States, focused on developing innovative therapies. With a market capitalization of approximately $450.5 million, Kyverna is positioned within the biotechnology sector. The company aims to advance its research and development efforts to address unmet medical needs.
Latest news from Kyverna Therapeutics, Inc.
Kyverna Therapeutics to Present at Upcoming Investor Conferences
September 2, 2026
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
August 11, 2026
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
July 27, 2026
Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-S...
June 22, 2026
Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, T...
June 3, 2026
Research Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for KYTX:BOATS.
Kyverna Therapeutics, Inc. company profile
View the public company page for Kyverna Therapeutics, Inc. on 6ix.
Kyverna Therapeutics, Inc. news
Read company news and market updates connected to Kyverna Therapeutics, Inc..
Kyverna Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Kyverna Therapeutics, Inc..